Top 15 Leading Players in India Wegovy Market | Competitive Landscape 2026

Code: MTA12085 Publication Date: Apr 2026

Top 15 Leading Players in India Wegovy Market

India Wegovy market represents a dynamic segment within the national metabolic healthcare sector, following recent shifts in international patent protections. Novo Nordisk, Sun Pharmaceutical Industries, Dr. Reddy's Laboratories, and Zydus Lifesciences are among the companies at the forefront of the weight-management revolution.

For detailed forecasts, data tables, and competitive benchmarking,
Explore the full India Wegovy market.

India Wegovy Market Overview

According to 6Wresearch, the India Wegovy market has entered a phase of significant expansion and accessibility. While the innovator brand gained an early presence, the environment was irreversibly transformed when Indian generic manufacturers entered following the expiration of core molecular protections. This shift has resulted in significant price reductions, making advanced receptor agonists available to a broader population beyond premium urban areas. Furthermore, this growth is being driven by rising clinical identification of obesity as a chronic condition, as well as intense medical detailing and digital patient-support programs aimed at improving therapeutic outcomes throughout the subcontinent.

Competitive Landscape

The competitive landscape in India is currently a strategic battle between global innovators and domestic generic giants. Success is no longer determined solely by the molecule but by device innovation, cold-chain integrity, and aggressive pricing strategies aimed at capturing the massive middle-income patient base.

Below is a list of leading players operating in the India Wegovy Market:

1. Novo Nordisk A/S

Company Name Novo Nordisk A/S
Established Year 1923
Headquarters Bagsværd, Denmark
Official Website Click Here

The innovator behind Wegovy; it maintains a premium market share through its high-quality "FlexPen" delivery system and co-marketing alliances.

2. Sun Pharmaceutical Industries Ltd.

Company Name Sun Pharmaceutical Industries Ltd.
Established Year 1983
Headquarters Mumbai, India
Official Website Click Here

A major force in the post-patent era, Sun Pharma launched Noveltreat and Sematrinity, covering the full titration ladder with competitive pricing.

3. Dr. Reddy's Laboratories

Company Name Dr. Reddy's Laboratories
Established Year 1984
Headquarters Hyderabad, India
Official Website Click Here

Launched Obeda, the first DCGI-approved generic semaglutide injection in India, emphasizing clinical non-inferiority and high manufacturing standards.

4. Zydus Lifesciences Limited

Company Name Zydus Lifesciences Limited
Established Year 1952
Headquarters Ahmedabad, India
Official Website Click Here

Differentiates itself through the Semaglyn brand, utilizing a reusable pen and cartridge system to reduce device waste and long-term costs.

5. Alkem Laboratories Limited

Company Name Alkem Laboratories Limited
Established Year 1973
Headquarters Mumbai, India
Official Website Click Here

Marketed under the brand Semasize, Alkem offers one of the most affordable monthly therapy options in a pre-filled disposable pen format.

6. Cipla Limited

Company Name Cipla Limited
Established Year 1935
Headquarters Mumbai, India
Official Website Click Here

A key player that entered the market through strategic co-marketing agreements while developing its own internal semaglutide pipeline.

7. Lupin Limited

Company Name Lupin Limited
Established Year 1968
Headquarters Mumbai, India
Official Website Click Here

Holds semi-exclusive rights to co-market semaglutide under the brands Semanext and Livarise, leveraging its massive domestic formulation network.

8. Glenmark Pharmaceuticals Ltd.

Company Name Glenmark Pharmaceuticals Ltd.
Established Year 1977
Headquarters Mumbai, India
Official Website Click Here

Disrupted the market by launching GLIPIQ, providing a simplified vial format aimed at increasing patient accessibility.

9. Mankind Pharma Limited

Company Name Mankind Pharma Limited
Established Year 1991
Headquarters New Delhi, India
Official Website Click Here

Focuses on the Samakind brand, utilizing its unmatched rural and semi-urban distribution reach to drive GLP-1 adoption beyond major metros.

10. Natco Pharma Limited

Company Name Natco Pharma Limited
Established Year 1981
Headquarters Hyderabad, India
Official Website Click Here

Known for its aggressive pricing strategies, Natco markets Semanat (vials) and Semafull (pens) to target the value-conscious segment.

11. Biocon Limited

Company Name Biocon Limited
Established Year 1978
Headquarters Bengaluru, India
Official Website Click Here

A pioneer in peptide and biosimilar manufacturing, Biocon provides semaglutide for emerging markets and local distribution through strategic partners.

12. Torrent Pharmaceuticals Ltd.

Company Name Torrent Pharmaceuticals Ltd.
Established Year 1959
Headquarters Ahmedabad, India
Official Website Click Here

Focuses on the chronic care segment, offering semaglutide as part of its metabolic and cardiovascular portfolio through co-marketing alliances.

13. Emcure Pharmaceuticals Limited

Company Name Emcure Pharmaceuticals Limited
Established Year 1981
Headquarters Pune, India
Official Website Click Here

Markets Poviztra, an authorized brand of semaglutide in collaboration with global partners, targeting the premium weight-loss market.

14. MSN Laboratories

Company Name MSN Laboratories
Established Year 2003
Headquarters Hyderabad, India
Official Website Click Here

A critical API supplier and formulation player that facilitates the entry of multiple brands into the Indian market with high-quality raw materials.

15. Eris Lifesciences Limited

Company Name Eris Lifesciences Limited
Established Year 2007
Headquarters Ahmedabad, India
Official Website Click Here

Entered the fray with the Sundae brand, focusing on cardiometabolic health and patient education for long-term weight management.

Top 15 Leading Players in India Wegovy Market: FAQs

Firms focus on launching high-bioequivalence generics, introducing reusable pen devices, and aggressive pricing to dominate the expanding weight-loss sector.
Firms innovate by introducing reusable pen systems, ultra-low-cost vial formats, and digital patient-support programs to improve titration accuracy and adherence.
The market is led by the innovator Novo Nordisk, alongside dominant Indian generic manufacturers like Sun Pharma, Dr. Reddy’s, Zydus, and Alkem Laboratories.
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All